PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Hydroethanolic extract of stem bark showed efficacy in improving microvascular complications, specifically renal fibrosis and retinopathy, in STZ-diabetic rats [PMID:37674975]
Methanol leaf extract significantly reduced wet feces and intraluminal fluid accumulation in castor oil-induced diarrhea in albino Wistar mice [PMID:22221760]
Root extracts demonstrated anti-inflammatory activity by reducing croton oil-induced edema in mice ears [PMID:28480397]
Kino aqueous extract (KAST) inhibited Aβ release in cells expressing human Amyloid Precursor Protein and in primary neurons [PMID:25639816]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37583878 (2023) — Temperature and soil nutrients drive seed traits variation in Pterocarpus erinaceus (African rosewood) in Ghana. · Plant-environment interactions (Hoboken, N.J.)
- 2.PMID: 32518851 (2020) — Vulnerability of African Rosewood (Pterocarpus erinaceus, Fabaceae) natural stands to climate change and implications for silviculture in West Africa. · Heliyon
- 3.PMID: 37674975 (2023) — Improvement of microvascular complications in STZ-diabetic rats treated with Pterocarpus erinaceus Poir. extract. · Biochemistry and biophysics reports
- 4.PMID: 24192706 (2014) — Gamma-secretase inhibitor activity of a Pterocarpus erinaceus extract. · Neuro-degenerative diseases
- 5.PMID: 25639816 (2015)